Strep Throat Treatment Drugs Market

The global Strep Throat Treatment Drugs market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Penicillin Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Strep Throat Treatment Drugs include Merck & co., Pfizer, Abbott Laboratories, Johnson & Johnson, Roche, Novartis, Bristol-Myers Squibb, Eli Lily and Astra Zeneca, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
Penicillin or amoxicillin is the antibiotic of choice to treat group A strep pharyngitis. There has never been a report of a clinical isolate of group A strep that is resistant to penicillin. However, resistance to azithromycin and clarithromycin is common in some communities.
Strep Throat Treatment Drugs Market aims to provide a comprehensive presentation of the global market for Strep Throat Treatment Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Strep Throat Treatment Drugs. Strep Throat Treatment Drugs Market contains market size and forecasts of Strep Throat Treatment Drugs in global, including the following market information:
Global Strep Throat Treatment Drugs Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global top five companies in 2023 (%)
We surveyed the Strep Throat Treatment Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Strep Throat Treatment Drugs Market, by Type, 2019-2024, 2025-2030 ($ millions)
Global Strep Throat Treatment Drugs Market Segment Percentages, by Type, 2023 (%)
Penicillin
Amoxicillin
Global Strep Throat Treatment Drugs Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global Strep Throat Treatment Drugs Market Segment Percentages, by Application, 2023 (%)
Hospitals
Specialty Clinics
Diagnostic Laboratories
Global Strep Throat Treatment Drugs Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global Strep Throat Treatment Drugs Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Strep Throat Treatment Drugs revenues in global market, 2019-2024 (estimated), ($ millions)
Key companies Strep Throat Treatment Drugs revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck & co.
Pfizer
Abbott Laboratories
Johnson & Johnson
Roche
Novartis
Bristol-Myers Squibb
Eli Lily
Astra Zeneca
Bayer
Bausch Health
Outline of Major Chapters:
Chapter 1: Introduces the definition of Strep Throat Treatment Drugs, market overview.
Chapter 2: Global Strep Throat Treatment Drugs market size in revenue.
Chapter 3: Detailed analysis of Strep Throat Treatment Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Strep Throat Treatment Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.